MNMD
Mind Medicine Inc
NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY
$15.02
+1.01% today
Updated 2026-01-14
Market cap
$1.46B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.98
Dividend yield
—
52W range
$5 – $15
Volume
1.9M
Mind Medicine Inc (MNMD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-46559.00 | $-26636.00 | $-665984.00 | $-722451.00 | $-208119.00 | $-23.60M | $-45.82M | $-50.14M | $-64.36M | $-79.13M |
| Capital expenditures | $0.00 | $30098.00 | $2.15M | $1.04M | $313457.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | $-46559.00 | $-56734.00 | $-2.82M | $-1.77M | $-521576.00 | $-23.60M | $-45.82M | $-50.14M | $-64.36M | $-79.13M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $52.70M | $8.91M | — | — |